Last update:
Oncology & Cancer news
Is global cancer care losing its human touch?
A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...
1 hour ago
0
0
Safe new target against acute myeloid leukemia discovered
Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers. This is the main finding of the latest research by Dr. Marcus Buschbeck and Dr. René Winkler, researchers ...
11 hours ago
0
34
Dual-action mRNA vaccine takes aim at aggressive skin cancer
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response. ...
13 hours ago
0
68
Antibody therapy foils pancreatic cancer's sugar-based disguise to reawaken immune system
Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic tumors use a sugar-based ...
14 hours ago
0
1
Abnormal transport signal on mutant UBTF gene drives high-risk acute myeloid leukemia
Acute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in urgent need of novel therapeutic options. To better understand this disease and how to treat it, St. ...
9 hours ago
0
0
Indoor hydroponic gardening can improve mental health and quality of life for cancer patients
Indoor hydroponic gardening—a method of growing plants using nutrient-rich water instead of soil—could help cancer patients develop better mental health, eat a healthier diet and enjoy a better overall quality of life.
10 hours ago
0
10
For incarcerated people, study shows gaps exist in quality of cancer care
In the United States, the incarcerated population is aging. About 15% of incarcerated adults, or approximately 175,000 people, are now 55 years or older.
10 hours ago
0
0
How new advances in 3D bioprinting, organoids and organs on-a-chip aid in the fight against cancer
Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.
13 hours ago
0
1
Immunotherapy resistance in kidney cancer driven by myeloid cell signaling
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.
16 hours ago
0
2
Clinical trial sees dramatic results using radiation to treat breast cancer
Almost immediately after Theresa Greco was diagnosed with breast cancer in March, doctors asked her whether she wanted to participate in a clinical trial. The trial would do high-powered radiation targeted at her tumor prior ...
16 hours ago
0
0
Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer?
A small group of women with advanced breast cancer received a vaccine via a clinical trial more than 20 years ago. Today, they're all still alive. Scientists say that kind of long-term survival is almost unheard of for patients ...
Oct 31, 2025
0
61
DNA copy-number changes help melanoma develop resistance to immunotherapy, study finds
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer, evolves to resist immunotherapy and identifies a potential strategy to prevent or reverse ...
Oct 31, 2025
0
12
AI tool makes detection of skin cancer more accurate
Researchers at Fox Chase Cancer Center, Temple University's College of Engineering, and the Lewis Katz School of Medicine at Temple University have developed a new method that enhances the ability of artificial intelligence ...
Oct 31, 2025
0
0
BRCA2 research reveals a novel mechanism behind chemoresistance
One of the biggest challenges in cancer treatment is chemoresistance: Tumors that initially respond well to chemotherapy become resistant over time. When that happens, treatment options are often limited.
Oct 30, 2025
0
9
Americans have widespread misbeliefs about the cancer risks of alcohol, study finds
Despite clear evidence linking alcohol use to increased cancer risks, public awareness of this connection remains low in the U.S., according to new research from The University of Texas MD Anderson Cancer Center. Researchers ...
Oct 30, 2025
1
38
Experimental cancer drug shows exceptional tumor-fighting potential
A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies. Published in the journal Molecular Cancer, the study introduces a highly ...
Oct 30, 2025
0
0
Early clinical trial tests immune-boosting therapy before prostate cancer surgery
A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly injecting an immune-activating compound into prostate tumors before surgery appears safe and may help ...
Oct 30, 2025
0
0
Breast cancer risk varies between different hormonal contraceptives, research reveals
Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and ...
Oct 30, 2025
0
1
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...
Oct 30, 2025
0
0
FDA approves Blenrep for relapsed or refractory multiple myeloma
The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.
Oct 30, 2025
0
0
Safeguarding fertility: Study investigates key hormone for women with cancer choosing fertility preservation
Newly diagnosed female cancer patients of reproductive age have a very short window for storing their eggs and embryos before starting cancer treatment. This is a process known as fertility preservation (FP), which protects ...
Oct 30, 2025
0
0
From antibiotics to antimalarials: How repurposed drugs might keep cancer from returning
Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, sometimes years later. ...
Oct 30, 2025
0
0
A promising molecule against chemotherapy-induced neuropathies
Currently incurable, peripheral neuropathies are common neurological complications of chemotherapy, causing persistent pain, tingling and burning sensations in the feet and hands, sometimes even after treatment has ended. ...
Oct 30, 2025
0
0
